This content is machine translated Atopic dermatitis Empirical data with dupilumab confirm the empirical evidence The biologic Dupilumab has proven itself under “real-life” conditions and has already received an extension of approval in the EU for the age group 12 years and older. At the…
View Post 6 min This content is machine translated Pediatric Rheumatology Always puncture joints! In treatment-resistant severe cases, a biologic representative of a new class of substances is available. Several evaluations of different forms of therapy came up with exciting results. One study made…
View Post 1 min This content is machine translated Squamous cell carcinoma Pembrolizumab as first-line therapy reduces mortality rate In a phase III trial, pembrolizumab improved overall survival in patients with recurrent or metastatic head and neck squamous cell carcinoma.
View Post 4 min This content is machine translated Dermato-Oncology New strategies in the fight against skin cancer The latest dermato-oncological studies on prevention, diagnosis and therapy were the subject of the German Skin Cancer Congress. There are promising developments in melanoma therapy, in the treatment of basal…
View Post 3 min This content is machine translated Deposition dermatoses Amyloidoses: early detection of cutaneous symptoms crucial Amyloidoses are a rare form of deposit dermatoses caused by defective folding of proteins. Dermatological early detection is of great importance for the further course of the disease.
View Post 3 min This content is machine translated Colorectal Cancer Focus on combination therapies Triple for colorectal cancer – for the first time, studies have shown clear superiority of a triple combination of encorafenib, binimetinib and cetuximab in progressive metastatic colorectal tumors.
View Post 3 min This content is machine translated Oral anticoagulation New brooms sweep better!? In nonvalvular atrial fibrillation, treatment with oral anticoagulants is indicated. Many guidelines recommend the use of direct oral anticoagulants (DOAK) as first-line therapy. The advantage here is considered to be…
View Post 2 min This content is machine translated BCL-2 Inhibition The next chapter in blood cancer therapy is opened BCL-2 inhibition represents a milestone in the history of blood cancer treatment. Approved for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL), oral small molecule is now also…
View Post 3 min This content is machine translated Rare infections of the lung The worm is in it In the context of increasing mobility and more people coming from endemic areas, it is important to be aware of rare lung infections. Older or immunosuppressed patients in particular often…
View Post 2 min This content is machine translated Immune thrombocytopenia (ITP) The patient as the focus – a change of perspective For the treatment of immune thrombocytopenia (ITP), the use of thrombopoietin receptor agonists (TPO-RA) is currently under discussion. Although steroid administration as shock therapy is still the focus of therapy.
View Post 3 min This content is machine translated Acute exacerbations of obstructive airway diseases: Asthma (Part 1) Let’s not have any thunder! When asthma patients suffer from exacerbations, in at least two-thirds of cases they are triggered by either an allergy or an infection. In addition, however, there is also a not…
